Effect of Porphyridium sp. polysaccharide on malignant cell transformation by Moloney murine sarcoma virus

M Huleihel1, S Arad

  • 1The Institute forApplied Biosciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. mahmoudh@bgumail.bgu.ac.il

Anticancer Research
|August 11, 2001
PubMed

Insights

Red microalga polysaccharides inhibit mouse fibroblast cell transformation by MSV-124 virus. This natural compound may affect early and late stages of the virus replication cycle.

Area of Science:

  • Biotechnology
  • Marine Biology
  • Virology

Background:

  • Certain microalgae produce bioactive compounds with potential therapeutic applications.
  • Porphyridium sp. is a red microalga known for its unique polysaccharide composition.
  • Viral cell transformation poses a significant challenge in biological research and disease modeling.

Purpose of the Study:

  • To investigate the anti-cancer properties of polysaccharides from Porphyridium sp.
  • To determine the effect of Porphyridium sp. polysaccharide on Moloney murine sarcoma virus (MuSV-124) induced cell transformation.
  • To elucidate the stage of the viral replication cycle targeted by the polysaccharide.

Main Methods:

  • Treatment of mouse fibroblast cells with Porphyridium sp. polysaccharide.
  • Infection of cells with MSV-124 virus.
  • Assessment of cell transformation inhibition.
  • Evaluation of polysaccharide addition timing and reversibility.

Main Results:

  • Porphyridium sp. polysaccharide demonstrated significant inhibition of MSV-124 induced cell transformation.
  • Optimal inhibition occurred when the polysaccharide was added pre-infection or at the time of infection.
  • The inhibitory effect was reversible upon polysaccharide removal, suggesting a late-stage inhibition post-provirus integration.
  • Post-infection addition also reduced transformed cells, indicating potential effects on early viral replication steps like cell absorption.

Conclusions:

  • Porphyridium sp. polysaccharide exhibits potent anti-viral activity against MSV-124.
  • The polysaccharide interferes with both early and late stages of the viral replication cycle.
  • These findings highlight the potential of microalgal polysaccharides as novel antiviral agents.